>> kayla, thank you very much. a story that we're following very closely here at cnbc. right, of course, behind me here at new york stock exchange. seema mody joining us now. >> yeah. the fda approving a colo-rectal drug. deutsche banc modeling in $150 million in peak worldwide sales of the drug for regeneron. back to you, sue. >> thank you very much, seema. >>> on a big market day, we are hitting the coast coming up next on "power lunch." two big stories to tell you about when we come back. first up, it is the trial of the century out in san jose. key testimony coming today as apple and samsung fight over the patents. apple is up 1.5%. check out facebook. it is now up almost 10% on the trading session. stock, though, still a big loser since the ipo. jumping today, however. before the break, five big names that are moving today. we have a gain in microsoft. almost 4% in hp. and almost 3.25% in cisco. back in a minute. to follow? the equity summary score consolidates the ratings of up to 10 independent research providers into a single score that's weighted based on how a